SRT-2183
id:
srt-2183-319-17633389
title:
SRT-2183
text:
SRT-2183 is a drug in development by Sirtris Pharmaceuticals intended as a small-molecule activator of the sirtuin subtype SIRT1. It has similar activity in animal studies to another SIRT1 activator SRT-1720, but is closer in potency to resveratrol. In animal studies it was found to improve insulin sensitivity and lower plasma glucose levels in fat, muscle and liver tissue, and increased mitochondrial and metabolic function.
However, the claim that SRT-2183 is a SIRT1 activator has been question
brand slug:
wiki
category slug:
encyclopedia
description:
Organic compound, experimental pharmaceuticum
original url:
https://en.wikipedia.org/wiki/SRT-2183
date created:
date modified:
2023-05-25T11:16:14Z
main entity:
{"identifier":"Q7392861","url":"https://www.wikidata.org/entity/Q7392861"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/6b/SRT2183_skeletal.svg","width":296,"height":248}
fields total:
13
integrity:
15